← Back
Data updated: Mar 10, 2026
ACCORD BIOPHARMA INC.
GastroenterologyImmunology
ACCORD BIOPHARMA INC. is a biotechnology company focused on Gastroenterology, Immunology.
2024
Since
5
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 54%
1 drugs Phase 1: 1
Immunology 46%
1 drugs
Pipeline Strength Pro
Loading...